Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BGRUX | 61.72 | -0.19 | -0.31% |
| Baron Generational Growth R6 | |||
| TNVRX | 20.78 | -0.09 | -0.44% |
| 1290 GAMCO Small/Mid Cap Value R | |||
| FFVPX | 25.00 | -0.15 | -0.60% |
| Fidelity Advisor Blue Chip Value Z | |||
| GGDPX | 18.51 | -0.16 | -0.86% |
| Goldman Sachs Intl Sm Cp Insghts P | |||
| GNXIX | 15.05 | -0.17 | -1.12% |
| AlphaCentric Robotics and Automation I | |||